Age- and sex-specific risk of urogenital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A population-based self-controlled case-series study

Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population‐based study of older women and men with diabetes

(2019) Iliana C. Lega et al.   DIABETES OBESITY & METABOLISM

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

(2018) Thomas A Zelniker et al.   LANCET

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

(2018) Stephen D. Wiviott et al.   NEW ENGLAND JOURNAL OF MEDICINE

Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials

(2016) Dandan Li et al.   DIABETES OBESITY & METABOLISM

Self controlled case series methods: an alternative to standard epidemiological study designs

(2016) Irene Petersen et al.   BMJ-British Medical Journal

Self controlled case series methods: an alternative to standard epidemiological study designs

(2016) Irene Petersen et al.   BMJ-British Medical Journal

Efficacy and safety of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2 years

(2015) Xiang-Yang Liu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Urinary tract infections in patients with diabetes treated with dapagliflozin

(2013) Kristina M. Johnsson et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin

(2013) Kristina M. Johnsson et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Dapagliflozin for the Treatment of Type 2 Diabetes

(2012) Sarah L Anderson et al.   ANNALS OF PHARMACOTHERAPY

Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor

(2012) Paul Nyirjesy et al.   CURRENT MEDICAL RESEARCH AND OPINION

Incidence of genital infection among patients with type 2 diabetes in the UK General Practice Research Database

(2012) Ishan Hirji et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials

(2010) Niklas Hammar et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes

(2008) S. A. Jabbour et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE